New Daily Persistent Headache Survey — NDPH

New Daily Persistent Headache Clinical Trial

Official title:
New Daily Persistent Headache Patient Experience Survey

Status Active, not recruiting

Clinical Trial Summary

Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey. Research design: Online survey of patients with new daily persistent headache. Risks: Risks include a breach of confidentiality as well as fatigue from taking the survey online. Importance of knowledge that may recently be expected to result: The study aims to discover new information in a very understudied disease. This information could, in future studies, help change the diagnostic criteria or lead to new treatment options.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Headache
New Daily Persistent Headache
New Daily Persistent Headache (NDPH)

Clinical Trial Details

NCT number	NCT05984719
Study type	Observational
Source	The University of Texas Health Science Center, Houston
Contact
Status	Active, not recruiting
Phase
Start date	June 19, 2023
Completion date	August 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01920945` - OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study	Phase 2
Terminated	`NCT04260087` - New Daily Persistent Headache Biomarkers Study
Recruiting	`NCT05536050` - Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia
Not yet recruiting	`NCT05334927` - China HeadAche DIsorders RegiStry